Esperion Therapeutics, Inc. (ESPR) Stock Analysis

DELISTED 2026

What happened to Esperion Therapeutics, Inc. (ESPR) stock?

Esperion Therapeutics, Inc. (ESPR) no longer trades on public markets. It was delisted in July 2026. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: July 2026
Last recorded price (historical):: $3.18 (last quote on record before the July 2026 delisting; historical, not a current quote)

MCap: $661M| Target: $3.19 (Stored FMP targets · Captured Oct 4, 2026) (estimate, not advice)| 52-wk range: $1.13 – $4.17

Market cap $661M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Esperion Therapeutics, Inc. (ESPR). Esperion Therapeutics, Inc. focuses on developing and commercializing medicines for patients with elevated low-density lipoprotein cholesterol. Their lead products, NEXLETOL and NEXLIZET, target atherosclerotic cardiovascular disease and heterozygous familial hypercholesterolemia.

Last analyzed: May 9, 2026

Esperion Therapeutics, Inc. focuses on developing and commercializing medicines for patients with elevated low-density lipoprotein cholesterol. Their lead products, NEXLETOL and NEXLIZET, target atherosclerotic cardiovascular disease and heterozygous familial hypercholesterolemia.

These figures come from statements filed 13 months ago — the most recent this company has published.

Esperion Therapeutics, Inc. (ESPR) Healthcare & Pipeline Overview

Employees294

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 83% (not a measure of the evidence) Updated: May 9, 2026

More about this archive record

Can I still buy ESPR shares?

No. ESPR stopped trading on public markets in July 2026, so the shares are not available through a broker. Anything you see quoted for ESPR elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before ESPR stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Esperion Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated May 9, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Aug 4, 2026.

Data provided for informational purposes only.